Cabaletta Bio, Inc.

CABA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.7B · 156 employees
131
SEC Filings
$2.91
Close 2026-09-09
156
Employees

Business Summary

Cabaletta Bio is a late clinical-stage biotechnology company developing engineered CAR T cell therapies for autoimmune diseases. Its lead product, resecabtagene autoleucel (rese-cel), is a fully human CD19-CAR T construct designed to reset the immune system via transient B cell depletion. The company is running multiple Phase 1/2 trials (RESET-Myositis, RESET-SLE, RESET-SSc, RESET-MG, RESET-PV) and initiated a registrational trial for dermatomyositis and anti-synthetase syndrome in December 2025.

Latest Stock Quote

CABA 2026-09-09 $2.91 O:$3.28 H:$3.28 L:$2.9 Vol:6.5M VWAP:$3.0565
origin leaf: null

Next Earnings

expected 2026-12-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001759138-26-000011EDGAR111K words
2025-03-312024-12-310000950170-25-047201EDGAR122K words
2024-03-212023-12-310000950170-24-034422EDGAR109K words
2023-03-162022-12-310000950170-23-008298EDGAR—
2022-03-172021-12-310001564590-22-010726EDGAR—
2021-03-162020-12-310001564590-21-013329EDGAR—
2020-03-302019-12-310001564590-20-013929EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001759138-26-000039EDGAR80K words
2025-11-102025-09-300001193125-25-273280EDGAR79K words
2025-08-072025-06-300000950170-25-104573EDGAR77K words
2025-05-152025-03-310000950170-25-071971EDGAR73K words
2024-11-142024-09-300000950170-24-126733EDGAR75K words
2024-08-082024-06-300000950170-24-093325EDGAR74K words
2024-05-152024-03-310000950170-24-060045EDGAR72K words
2023-11-092023-09-300000950170-23-061528EDGAR74K words
2023-08-102023-06-300000950170-23-040966EDGAR73K words
2023-05-112023-03-310000950170-23-020849EDGAR73K words
2022-11-102022-09-300000950170-22-024168EDGAR—
2022-08-112022-06-300000950170-22-016650EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-140001759138-26-000041EDGAR1K words
2026-08-130001759138-26-000038EDGAR3K words
2026-03-230001759138-26-000010EDGAR3K words
2026-01-120001193125-26-009819EDGAR8K words
2025-11-100001193125-25-273272EDGAR3K words
2025-10-290001193125-25-254610EDGAR10K words
2025-10-270001193125-25-250676EDGAR9K words
2025-10-090001193125-25-235533EDGAR9K words
2025-09-030001759138-25-000007EDGAR8K words
2025-08-070000950170-25-104570EDGAR2K words

131 total filings indexed. 102 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

autoimmune-diseases dermatomyositis-and-anti-synthetase-syndrome systemic-lupus-erythematosus-and-lupus-nephritis systemic-sclerosis generalized-myasthenia-gravis pemphigus-vulgaris juvenile-idiopathic-inflammatory-myopathy 4-1bb-co-stimulatory-domain-car-t-construct fludarabine-and-cyclophosphamide-preconditioning-regimen weight-based-dosing-at-1.0-x-10^6-cells/kg

Company Identity

CIK0001759138
TickerCABA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.cabalettabio.com
Listed2019-10-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: b3faaac49c332931abe8d380de1335d23e47c22b47563a2a7a02087e9ed8a611
parent: 30a472da27ae730c0ebf21fa6f0ee1f1878469dbec33bae1d687e97b82b9dd52
content hash: 35b579a0955935dfbcaa6431b12b3658cb68565db565d7668d84fe16a0e59cfb
signed: 2026-09-28T19:00:38.626Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CABA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CABA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CABA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.